Rituximab in Interstitial Pneumonitis

NCT02251964 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lung Diseases, Interstitial
Pneumonitis, Interstitial

Interventions

DRUG: Rituximab
RADIATION: Zr-89-rituximab immuno PET/CT

Sponsor

Human Adams

Collaborators

[object Object]